Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial.
Mikhaildis
D P
DP
Wierzbicki
A S
AS
Reynolds
T M
TM
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D003327:Coronary Disease / Q000378:metabolism* / Q000628:therapy*; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D009204:Myocardial Revascularization; D011758:Pyrroles / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin